🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 17

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 255 replies 53,106 viewsPage 17 of 20
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Feb 27, 2024 at 4:05 PM#81

+1 to Dr.RenalNash. Especially the point about "gov thread who is feeling discouraged: i..." — I have seen the same in my own experience with ClinicalTrials.gov GLP-1.

Last edited: Feb 27, 2024 at 8:05 PM
42 21MariaRD, AussieAnna, BethLabQueen and 39 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Feb 27, 2024 at 4:22 PM#82

Yep. My endo said the same thing about ClinicalTrials.gov.

43 14Dr.EndoEP, GraceAZ_72, carl_compliance and 40 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Feb 27, 2024 at 4:39 PM#83

+1 to adam_van. Especially the point about "Follow-up question: did you change anyth..." — I have seen the same in my own experience with ClinicalTrials.gov GLP-1.

Last edited: Feb 27, 2024 at 5:39 PM
13 7oliver_london, tane_welly, Dr.PathRoch and 10 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Feb 27, 2024 at 4:56 PM#84

Following this thread closely. ClinicalTrials.gov GLP-1 is something I'm actively working through.

35 21tom_AK, josh_phd_bmore, roxy_nash and 32 others
Reply Quote Save Share Report
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Feb 27, 2024 at 5:13 PM#85

+1 to Dr.RenalNash. Especially the point about "gov thread who is feeling discouraged: i..." — I have seen the same in my own experience with ClinicalTrials.gov GLP-1.

Last edited: Feb 27, 2024 at 6:13 PM
29 3mike_mealprep, NicoleRaleigh, james_edin and 26 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register